News: Parexel International Corporation (PRXL.O)
13.90USD
2:10pm EST
$0.31 (+2.28%)
$13.59
$13.60
$13.98
$13.55
246,416
299,324
$16.62
$7.20
Tue, Oct 27 2009
UPDATE 1-Parexel posts lower Q1 profit, sees Q2 below estimates
Oct 27 (Reuters) - Clinical research service provider Parexel International Corp posted a lower quarterly profit as consolidation among drugmakers created unevenness in demand for the company's services, and forecast second-quarter adjusted profit slightly below market estimates.
HEADLINE STOCKS-Some U.S. stocks on the move on August 11
(Updates to after the open, adds Bridgepoint, QLogic, Broadridge Financial, BP/Martek, Anthracite, PetSmart and Anadys)
HEADLINE STOCKS-Some U.S. stocks to watch on August 11
NEW YORK, Aug 11 (Reuters) - Some U.S. stocks to watch on Tuesday:
HEADLINE STOCKS-U.S. stocks on the move on April 28
(Updates to afternoon trade, adds Agco, Valero, Olin and Celanese)
HEADLINE STOCKS-U.S. stocks on the move on April 28
(Updates to after the open, adds IBM, Bristol-Myers, Interpublic, Coca-Cola Enterprises, Fortune Brands)
HEADLINE STOCKS-U.S. stocks to watch on April 28
NEW YORK, April 28 (Reuters) - Some U.S. stocks to watch on Tuesday:
UPDATE 1-Parexel posts flat Q3 profit, ups '09 profit view
April 27 (Reuters) - Parexel International Corp posted a flat quarterly profit as higher expenses offset an 8 percent increase in service revenue, and the company raised its profit forecast for 2009, sending its shares up 15 percent.
UPDATE 2-PPD shares tumble on lowered outlook
* Cuts 2009 outlook (Adds analyst comment, updates share movement)
UPDATE 2-Kendle shares tumble 61 percent on weak outlook
* Q1 cancellation rate more than 45 pct (Adds analyst comments, updates share price)
US RESEARCH SUMMARY-Non-S&P 500 Feb 2 1633 GMT
Following is a summary of research actions on non-S&P 500 companies reported
- Pharma Researchers Need a Cure
- Pundits Are Wrong: Healthcare Reform Will Increase Profits
- 'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers
- PAREXEL International Corp. F4Q09 (Qtr End 06/30/09) Earnings Call Transcript
- Ariad Pharmaceuticals: Advancing in Front of Phase 3 Interim Results
- Spectrum Pharmaceuticals: Outlook Remains Very Promising
Press Releases
- Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite
- PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference
- PAREXEL Experts to Discuss Impact of Pharmacovigilance Trends on Biosimilars and Generics at World Generic Medicines Congress Americas
- Perceptive Informatics Expands Nuclear Imaging Capabilities for Cardiology Trials
- PAREXEL Experts to Discuss Global Capabilities to Meet Urgent Demand For Cardiovascular Treatments at AHA Scientific Sessions
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
